Coloplast AS (Spons ADRS) is expected to look into the books on May 6, 2025: At the quarterly financial conference, Coloplast AS (Spons ADRS) will disclose the balance sheet to the annual quarter ended on March 31, 2025.
The forecasts of 9 analysts for the latest annual quarter amount to an EPS of USD 0.078 per share. A year earlier, Coloplast AS (Spons ADRS) had a profit of $ 0.080 per share in the books.
12 analysts go on average of USD 1.03 billion – this would correspond to an increase of 7.00 percent compared to the same period in the previous year. At that time, $ 958.7 million were generated.
Looking at the entire current fiscal year, 23 analysts expect an average of $ 0.347 per share. In the previous year, a profit of $ 0.330 was reported here. 22 analysts estimate the turnover to $ 4.20 billion, compared to $ 3.93 billion in the previous year.
Editor finance.net
By the way: Coloplast as (spons. ADRS) and other US shares are even tradable at Finance.net Zero until 11 p.m. (without order fees, plus spreads). Open Depot now for free And receive a free stock as a gift.
Selected leverage products on Coloplast as (spons. ADRS)
With knock-outs, speculative investors can participate disproportionately in price movements. Simply choose the desired lever and we will show you suitable open-end products on Coloplast as (spons. Adrs)
The lever must be between 2 and 20
Advertising